Viewing Study NCT01441960


Ignite Creation Date: 2025-12-25 @ 2:01 AM
Ignite Modification Date: 2026-05-24 @ 7:08 PM
Study NCT ID: NCT01441960
Status: COMPLETED
Last Update Posted: 2015-06-02
First Post: 2011-09-20
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Optimal Dose of Succinylcholine and Rocuronium for Electroconvulsive Therapy (ECT)
Sponsor: Massachusetts General Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neuromuscular Blockade View
None ECT View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Succinylcholine View
None Rocuronium View
None ECT View